Pediatric acute lymphoblastic leukemia: redefining outcomes

J Pediatr Hematol Oncol. 2002 Feb;24(2):88. doi: 10.1097/00043426-200202000-00005.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Attention / drug effects
  • Child
  • Child, Preschool
  • Cognition Disorders / epidemiology
  • Cognition Disorders / etiology*
  • Combined Modality Therapy
  • Cranial Irradiation / adverse effects
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Drug Administration Routes
  • Humans
  • Hydrocortisone / administration & dosage
  • Hydrocortisone / adverse effects
  • Infant
  • Learning Disabilities / epidemiology
  • Learning Disabilities / etiology
  • Memory Disorders / epidemiology
  • Memory Disorders / etiology
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Neuropsychological Tests
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / psychology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Survivors / psychology*
  • Treatment Outcome*

Substances

  • Cytarabine
  • Dexamethasone
  • Prednisone
  • Hydrocortisone
  • Methotrexate